KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aterian (ATER) EBT (2018 - 2025)

Historic EBT for Aterian (ATER) over the last 8 years, with Q3 2025 value amounting to -$2.3 million.

  • Aterian's EBT fell 1406.96% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.4 million, marking a year-over-year increase of 3547.41%. This contributed to the annual value of -$11.9 million for FY2024, which is 8421.21% up from last year.
  • According to the latest figures from Q3 2025, Aterian's EBT is -$2.3 million, which was down 1406.96% from -$4.8 million recorded in Q2 2025.
  • Aterian's 5-year EBT high stood at -$1.4 million for Q4 2024, and its period low was -$117.0 million during Q3 2022.
  • For the 5-year period, Aterian's EBT averaged around -$27.9 million, with its median value being -$8.7 million (2023).
  • As far as peak fluctuations go, Aterian's EBT plummeted by 1363105.59% in 2021, and later skyrocketed by 9471.69% in 2023.
  • Over the past 5 years, Aterian's EBT (Quarter) stood at -$6.1 million in 2021, then tumbled by 232.81% to -$20.4 million in 2022, then soared by 57.35% to -$8.7 million in 2023, then surged by 83.81% to -$1.4 million in 2024, then tumbled by 60.31% to -$2.3 million in 2025.
  • Its EBT stands at -$2.3 million for Q3 2025, versus -$4.8 million for Q2 2025 and -$3.9 million for Q1 2025.